Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Completed · Phase 2

Conditions studied: Psoriasis

In brief

Safety and Efficacy of IDP-118 Lotion to Ultravate® Cream, in the Treatment of Plaque Psoriasis

Key facts

Study ID

NCT02785172

Run by

Bausch Health Americas, Inc.

People needed

154

Starts

2016-04-01

Expected to finish

2017-01-01

Last updated by the study team

2020-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Valeant Site 12 — Fullerton, California, United States
• Valeant Site 04 — La Mesa, California, United States
• Valeant Site 03 — San Diego, California, United States
• Valeant Site 09 — San Diego, California, United States
• Valeant Site 05 — Lauderdale Lakes, Florida, United States
• Valeant Site 02 — Miami, Florida, United States
• Valeant Site 07 — Fridley, Minnesota, United States
• Valeant Site 08 — Chapel Hill, North Carolina, United States
• Valeant Site 06 — Columbus, Ohio, United States
• Valeant Site 13 — Mt. Pleasant, South Carolina, United States
• Valeant Site 11 — Katy, Texas, United States
• Valeant Site 10 — San Antonio, Texas, United States
• Valeant Site 01 — Sugar Land, Texas, United States
• Valeant Site 14 — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.